Michal Alon Selected Research

Interferons

1/2021

Anti-tumour immunity induces aberrant peptide presentation in melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michal Alon Research Topics

Disease

9	Melanoma (Melanoma, Malignant) 11/2022 - 01/2018
7	Neoplasms (Cancer) 01/2023 - 07/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Inflammation (Inflammations) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Hypercalciuria 05/2004
1	Urolithiasis 05/2004

Drug/Important Bio-Agent (IBA)

3	Peptides (Polypeptides)IBA 01/2023 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 11/2022 - 12/2018
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2020
2	trametinibIBA 01/2020 - 07/2018
2	GTP Phosphohydrolases (GTPases)IBA 12/2018 - 07/2018
2	CalciumIBA 07/2018 - 05/2004
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023
1	InterferonsIBA 01/2021
1	Tryptophan (L-Tryptophan)FDA Link 01/2021
1	16S Ribosomal RNAIBA 01/2021
1	takinibIBA 01/2020
1	A-factor (Streptomyces)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Interferon-gamma (Interferon, gamma)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	F-Box ProteinsIBA 01/2020
1	Valine (L-Valine)FDA Link 12/2018
1	Cysteine (L-Cysteine)FDA Link 12/2018
1	DisulfidesIBA 12/2018
1	Neurofibromin 1 (Neurofibromin)IBA 07/2018
1	Small Interfering RNA (siRNA)IBA 07/2018
1	Cysteine Proteases (Cysteine Protease)IBA 07/2018
1	acetylleucyl-leucyl-norleucinalIBA 07/2018
1	Oncogene Proteins (Oncogene Protein)IBA 01/2018
1	EpitopesIBA 01/2018
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018
1	PotassiumIBA 05/2004
1	ThiazidesIBA 05/2004
1	SodiumIBA 05/2004
1	Potassium Citrate FDA LinkGeneric 05/2004

Therapy/Procedure

3	Immunotherapy 01/2023 - 01/2020
2	Therapeutics 01/2020 - 01/2020